Fidelity Group of Funds > Fidelity Select Portfolios
Select Biotechnology Portfolio
$4.60B
Avg Monthly Net Assets
$4.70B
Total Assets
$237.11M
Total Liabilities
$4.47B
Net Assets
Select Biotechnology Portfolio is a Mutual Fund in Fidelity Select Portfolios
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has one share class
and monthly net assets of $4.60B.
On July 26th, 2024 it reported 198 holdings, the largest
being ABBVIE INC (12.0%), AMGEN INC (8.7%) and KRYSTAL BIOTECH INC (6.9%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Select Biotechnology Portfolio | C000020460 | FBIOX |
Holdings
From latest NPORT-P, filed July 26th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $4M | 172K | 0.09 |
| 4D MOLECULAR THERAPEUTICS INC | Long | Equity-common | US | $743K | 31K | 0.02 |
| ABBVIE INC | Long | Equity-common | US | $538M | 3M | 12.04 |
| ABSCI CORP | Long | Equity-common | US | $940K | 223K | 0.02 |
| AC IMMUNE SA | Long | Equity-common | CH | $126K | 27K | 0.00 |
| ACELYRIN INC | Long | Equity-common | US | $637K | 155K | 0.01 |
| ADVERUM BIOTECHNOLOGIES INC | Long | Equity-common | US | $5M | 648K | 0.11 |
| AEROVATE THERAPEUTICS INC | Long | Equity-common | US | $4M | 210K | 0.08 |
| AFFERENT PHARMACEUTICALS INC CONTINGENT VALUE RT 12/31/24 | Long | Equity-common | US | $2M | 8M | 0.04 |
| AFFERENT PHARMACEUTICALS INC SER C PC PP | Long | Equity-preferred | US | $82.75 | 8M | 0.00 |
| ALECTOR INC | Long | Equity-common | US | $17M | 4M | 0.39 |
| ALLENA PHARMACEUTICALS INC | Long | Equity-common | US | $0.94 | 94K | 0.00 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $7M | 3M | 0.16 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $103M | 692K | 2.30 |
| ALTO NEUROSCIENCE INC | Long | Equity-common | US | $2M | 169K | 0.05 |
| ALX ONCOLOGY HOLDINGS INC | Long | Equity-common | US | $10M | 939K | 0.22 |
| AMGEN INC | Long | Equity-common | US | $389M | 1M | 8.71 |
| AMICUS THERAPEUTICS INC | Long | Equity-common | US | $4M | 406K | 0.09 |
| ANAPTYSBIO INC | Long | Equity-common | US | $5M | 195K | 0.10 |
| ANNEXON INC | Long | Equity-common | US | $1M | 309K | 0.03 |
| APELLIS PHARMACEUTICALS INC | Long | Equity-common | US | $50M | 1M | 1.13 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $18M | 392K | 0.40 |
| ARADIGM CORP | Long | Equity-common | US | $0.12 | 12K | 0.00 |
| ARADIGM CORP PIPE | Long | Equity-common | US | $1.48 | 148K | 0.00 |
| ARCELLX INC | Long | Equity-common | US | $66M | 1M | 1.48 |
| ARCTURUS THERAPEUTICS HOLDINGS INC | Long | Equity-common | US | $23M | 589K | 0.51 |
| ARCUS BIOSCIENCES INC | Long | Equity-common | US | $36M | 2M | 0.81 |
| ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $42M | 113K | 0.94 |
| ARRIVENT BIOPHARMA INC | Long | Equity-common | US | $35M | 2M | 0.78 |
| ARROWHEAD PHARMACEUTICALS INC | Long | Equity-common | US | $16M | 713K | 0.37 |
| ARS PHARMACEUTICALS INC | Long | Equity-common | US | $10M | 1M | 0.22 |
| ARVINAS INC | Long | Equity-common | US | $10M | 297K | 0.22 |
| ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $89M | 659K | 1.99 |
| ASTRIA THERAPEUTICS INC | Long | Equity-common | US | $4M | 413K | 0.09 |
| ASTRIA THERAPEUTICS INC WT | Long | Equity-common | US | $551K | 115K | 0.01 |
| ATEA PHARMACEUTICALS INC | Long | Equity-common | US | $4M | 958K | 0.08 |
| ATYR PHARMA INC | Long | Equity-common | US | $4M | 2M | 0.09 |
| AURA BIOSCIENCES INC | Long | Equity-common | US | $2M | 230K | 0.04 |
| AUTOLUS THERAPEUTICS LTD ADR (AUTOLUS THERAPEUTICS PLC) | Long | Equity-common | GB | $2M | 454K | 0.04 |
| AVIDITY BIOSCIENCES (AVIDITY BIOSCIENCES INC) | Long | Equity-common | US | $22M | 834K | 0.50 |
| AXCELLA HEALTH INC | Long | Equity-common | US | $0.66 | 66K | 0.00 |
| AXSOME THERAPEUTICS INC | Long | Equity-common | US | $10M | 137K | 0.23 |
| BEAM THERAPEUTICS INC | Long | Equity-common | US | $13M | 528K | 0.28 |
| BEIGENE LTD SP ADR | Long | Equity-common | KY | $1M | 9K | 0.03 |
| BEYONDSPRING INC | Long | Equity-common | KY | $1M | 464K | 0.03 |
| BIO AB2 HOLDINGS LLC ADI (BIO AB HOLDINGS LLC) | Long | Equity-common | US | $11M | 2M | 0.24 |
| BIO AB2 HOLDINGS LLC ARC (BIO AB HOLDINGS LLC) | Long | Equity-common | US | $37M | 2M | 0.83 |
| BIOCRYST PHARMACEUTICALS INC | Long | Equity-common | US | $12M | 2M | 0.26 |
| BIOGEN INC | Long | Equity-common | US | $28M | 122K | 0.62 |
| BIOHAVEN LTD | Long | Equity-common | VG | $64M | 2M | 1.42 |
| BIOMEA FUSION INC | Long | Equity-common | US | $4M | 393K | 0.09 |
| BIOXCEL THERAPEUTICS INC | Long | Equity-common | US | $160K | 88K | 0.00 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $68M | 640K | 1.51 |
| BOUNDLESS BIO INC | Long | Equity-common | US | $216K | 24K | 0.00 |
| BRIDGEBIO PHARMA INC | Long | Equity-common | US | $19M | 689K | 0.43 |
| BRIDGEBIO PHARMA INC PIPE | Long | Equity-common | US | $21M | 733K | 0.46 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $5M | 237K | 0.10 |
| CARTESIAN THERAPEUTICS INC | Long | Equity-common | US | $18M | 509K | 0.40 |
| CARTESIAN THERAPEUTICS INC CVR RT | Long | Equity-common | US | $754K | 5M | 0.02 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $28M | 829K | 0.62 |
| CENTESSA PHARMACEUTICALS LTD ADR (CENTESSA PHARMACEUTICALS PLC) | Long | Equity-common | GB | $24M | 3M | 0.54 |
| CHINOOK THERAPEUTICS INC CVR RT | Long | Equity-common | US | $1.16 | 116K | 0.00 |
| CODIAK BIOSCIENCES INC | Long | Equity-common | US | $4.49 | 449K | 0.00 |
| CODIAK BIOSCIENCES INC WT 09/15/2027 | Long | Equity-common | US | $0.46 | 46K | 0.00 |
| COGENT BIOSCIENCES INC | Long | Equity-common | US | $9M | 1M | 0.20 |
| CONTINEUM THERAPEUTICS INC CL A | Long | Equity-common | US | $901K | 59K | 0.02 |
| CORCEPT THERAPEUTICS INC | Long | Equity-common | US | $25M | 822K | 0.56 |
| CRINETICS PHARMACEUTICALS INC | Long | Equity-common | US | $50M | 1M | 1.11 |
| CRISPR THERAPEUTICS AG | Long | Equity-common | CH | $11M | 202K | 0.24 |
| CYCLERION THERAPEUTICS INC | Long | Equity-common | US | $112K | 42K | 0.00 |
| CYCLERION THERAPEUTICS INC PP PIPE | Long | Equity-common | US | $13K | 5K | 0.00 |
| CYTOKINETICS INC | Long | Equity-common | US | $18M | 381K | 0.41 |
| DAY ONE BIOPHARMACEUTICALS INC | Long | Equity-common | US | $12M | 909K | 0.27 |
| DENALI THERAPEUTICS INC | Long | Equity-common | US | $4M | 200K | 0.08 |
| DIANTHUS THERAPEUTICS INC | Long | Equity-common | US | $5M | 236K | 0.11 |
| DISC MEDICINE INC | Long | Equity-common | US | $14M | 404K | 0.31 |
| DISC MEDICINE INC CVR RT | Long | Equity-common | US | $15.56 | 2M | 0.00 |
| DYNE THERAPEUTICS INC | Long | Equity-common | US | $19M | 600K | 0.43 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $8M | 475K | 0.18 |
| ELEVATEBIO LLC SER C PC PP (ELEVATEBIO, LLC) | Long | Equity-preferred | US | $663K | 217K | 0.01 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $11M | 500K | 0.25 |
| ENTRADA THERAPEUTICS INC | Long | Equity-common | US | $2M | 151K | 0.05 |
| EXELIXIS INC | Long | Equity-common | US | $4M | 179K | 0.09 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $13M | 13M | 0.28 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $221M | 221M | 4.96 |
| FOGHORN THERAPEUTICS INC | Long | Equity-common | US | $5M | 907K | 0.12 |
| FULCRUM THERAPEUTICS INC | Long | Equity-common | US | $10M | 1M | 0.22 |
| GALDERMA GROUP AG | Long | Equity-common | CH | $7M | 82K | 0.15 |
| GERON CORP | Long | Equity-common | US | $13M | 4M | 0.28 |
| GERON CORP WT 07/02/2024 | Long | Equity-common | US | $2M | 2M | 0.05 |
| GH RESEARCH PLC | Long | Equity-common | IE | $4M | 256K | 0.08 |
| GILEAD SCIENCES INC | Long | Equity-common | US | $90M | 1M | 2.00 |
| GLAUKOS CORP | Long | Equity-common | US | $643K | 6K | 0.01 |
| GOSSAMER BIO INC | Long | Equity-common | US | $5M | 8M | 0.10 |
| GRITSTONE BIO INC | Long | Equity-common | US | $994K | 1M | 0.02 |
| GRITSTONE BIO INC WT | Long | Equity-common | US | $13.33 | 1M | 0.00 |
| HARMONY BIOSCIENCES HOLDINGS INC | Long | Equity-common | US | $3M | 92K | 0.06 |
| IDEAYA BIOSCIENCES (IDEAYA BIOSCIENCES INC) | Long | Equity-common | US | $38M | 1M | 0.86 |
| IDORSIA LTD | Long | Equity-common | CH | $9M | 3M | 0.19 |
| IGM BIOSCIENCES INC | Long | Equity-common | US | $7M | 881K | 0.16 |
| IMMUNOCORE HOLDINGS LTD ADR (IMMUNOCORE HOLDINGS PLC) | Long | Equity-common | GB | $10M | 208K | 0.23 |
| IMMUNOME INC | Long | Equity-common | US | $7M | 484K | 0.16 |
| IMMUNOVANT INC | Long | Equity-common | US | $20M | 789K | 0.45 |
| INDIVIOR PLC | Long | Equity-common | GB | $1M | 72K | 0.03 |
| INOZYME PHARMA INC | Long | Equity-common | US | $12M | 2M | 0.27 |
| INSMED INC | Long | Equity-common | US | $65M | 1M | 1.45 |
| INTELLIA THERAPEUTICS INC | Long | Equity-common | US | $18M | 824K | 0.39 |
| INTRA-CELLULAR THERAPIES INC | Long | Equity-common | US | $9M | 134K | 0.20 |
| IO BIOTECH INC | Long | Equity-common | US | $374K | 315K | 0.01 |
| IONIS PHARMACEUTICALS INC | Long | Equity-common | US | $31M | 831K | 0.70 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $20M | 366K | 0.44 |
| KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $18M | 389K | 0.41 |
| KORRO BIO INC | Long | Equity-common | US | $5M | 92K | 0.11 |
| KORRO BIO INC PIPE | Long | Equity-common | US | $2M | 33K | 0.04 |
| KRYSTAL BIOTECH INC | Long | Equity-common | US | $306M | 2M | 6.85 |
| KYMERA THERAPEUTICS INC | Long | Equity-common | US | $15M | 456K | 0.33 |
| LEGEND BIOTECH CORP SPON ADR | Long | Equity-common | KY | $24M | 600K | 0.54 |
| LEXICON PHARMACEUTICALS INC | Long | Equity-common | US | $285K | 168K | 0.01 |
| LEXICON PHARMACEUTICALS INC PIPE | Long | Equity-common | US | $8M | 5M | 0.18 |
| LONGBOARD PHARMACEUTICALS INC | Long | Equity-common | US | $34M | 2M | 0.75 |
| MADRIGAL PHARMACEUTICALS INC | Long | Equity-common | US | $22M | 91K | 0.48 |
| MANNKIND CORP | Long | Equity-common | US | $21M | 4M | 0.46 |
| MEDAVAIL HOLDINGS INC PIPE | Long | Equity-common | US | $0.02 | 55 | 0.00 |
| MERUS B.V. (MERUS NV) | Long | Equity-common | NL | $64M | 1M | 1.42 |
| MODERNA INC | Long | Equity-common | US | $108M | 760K | 2.42 |
| MONTE ROSA THERAPEUTICS INC | Long | Equity-common | US | $4M | 1M | 0.10 |
| MOONLAKE IMMUNOTHERAPEUTICS | Long | Equity-common | KY | $7M | 180K | 0.16 |
| MORPHIC HOLDING INC | Long | Equity-common | US | $31M | 1M | 0.69 |
| NATERA INC | Long | Equity-common | US | $38M | 357K | 0.85 |
| NATIONAL RESILIENCE INC SER B PC PP | Long | Equity-preferred | US | $28M | 732K | 0.63 |
| NOVO-NORDISK AS CL B ADR | Long | Equity-common | DK | $7M | 52K | 0.16 |
| NOVOCURE LTD | Long | Equity-common | JE | $245K | 11K | 0.01 |
| NURIX THERAPEUTICS INC | Long | Equity-common | US | $205K | 13K | 0.00 |
| NUVALENT INC-A | Long | Equity-common | US | $15M | 234K | 0.34 |
| NUVATION BIO INC | Long | Equity-common | US | $10M | 3M | 0.22 |
| OMEGA THERAPEUTICS INC | Long | Equity-common | US | $485K | 245K | 0.01 |
| OPTINOSE INC | Long | Equity-common | US | $485K | 449K | 0.01 |
| OPTINOSE INC WT 11/23/27 | Long | Equity-common | US | $16K | 92K | 0.00 |
| ORIC PHARMACEUTICALS INC | Long | Equity-common | US | $1M | 117K | 0.02 |
| PEPGEN INC | Long | Equity-common | US | $6M | 388K | 0.14 |
| PHARVARIS BV | Long | Equity-common | NL | $2M | 112K | 0.05 |
| PLIANT THERAPEUTICS INC | Long | Equity-common | US | $454K | 37K | 0.01 |
| POSEIDA THERAPEUTICS INC | Long | Equity-common | US | $668K | 223K | 0.01 |
| PRAXIS PRECISION MEDICINES INC (PRAXIS PRECISION MEDICINES INC.) | Long | Equity-common | US | $16M | 344K | 0.37 |
| PROTAGONIST THERAPEUTICS INC | Long | Equity-common | US | $12M | 424K | 0.27 |
| PROTHENA CORP PLC | Long | Equity-common | IE | $15M | 738K | 0.34 |
| PTC THERAPEUTICS INC | Long | Equity-common | US | $24M | 671K | 0.55 |
| RALLYBIO CORP | Long | Equity-common | US | $970K | 581K | 0.02 |
| RAPT THERAPEUTICS INC | Long | Equity-common | US | $3M | 803K | 0.07 |
| RECURSION PHARMACEUTICALS INC | Long | Equity-common | US | $1M | 150K | 0.03 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $215M | 219K | 4.81 |
| REGULUS THERAPEUTICS INC | Long | Equity-common | US | $7M | 3M | 0.15 |
| REPLIMUNE GROUP INC | Long | Equity-common | US | $2M | 420K | 0.05 |
| REVOLUTION MEDICINES INC | Long | Equity-common | US | $24M | 619K | 0.53 |
| RHYTHM PHARMACEUTICALS INC | Long | Equity-common | US | $557K | 16K | 0.01 |
| ROCKET PHARMACEUTICALS INC | Long | Equity-common | US | $11M | 533K | 0.25 |
| ROIVANT SCIENCES LTD | Long | Equity-common | BM | $35M | 3M | 0.79 |
| SAGE THERAPEUTICS INC | Long | Equity-common | US | $14M | 1M | 0.31 |
| SALIOGEN THERAPEUTICS INC SER B PC PP | Long | Equity-preferred | US | $6M | 94K | 0.14 |
| SANA BIOTECHNOLOGY INC | Long | Equity-common | US | $3M | 466K | 0.08 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $51M | 390K | 1.13 |
| SCHOLAR ROCK HOLDING CORP | Long | Equity-common | US | $15M | 2M | 0.34 |
| SCHOLAR ROCK HOLDING CORP WT 12/31/2025 PP | Long | Equity-common | US | $63K | 18K | 0.00 |
| SCHRODINGER INC | Long | Equity-common | US | $9M | 398K | 0.19 |
| SCORPION THERAPEUTICS INC SER B PC PP | Long | Equity-preferred | US | $7M | 3M | 0.16 |
| SENSORION SA | Long | Equity-common | FR | $17M | 20M | 0.38 |
| SERES THERAPEUTICS INC | Long | Equity-common | US | $854K | 854K | 0.02 |
| SHATTUCK LABS INC | Long | Equity-common | US | $4M | 482K | 0.08 |
| SPRINGWORKS THERAPEUTICS INC | Long | Equity-common | US | $20M | 493K | 0.46 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $9M | 262K | 0.20 |
| STOKE THERAPEUTICS INC | Long | Equity-common | US | $6M | 392K | 0.13 |
| STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $8M | 227K | 0.17 |
| SUMMIT THERAPEUTICS INC | Long | Equity-common | US | $39M | 4M | 0.87 |
| TANGO THERAPEUTICS INC | Long | Equity-common | US | $2M | 310K | 0.05 |
| TANGO THERAPEUTICS INC PIPE | Long | Equity-common | US | $3M | 467K | 0.07 |
| TAYSHA GENE THERAPIES INC | Long | Equity-common | US | $26M | 8M | 0.59 |
| TECTONIC THERAPEUTIC INC PIPE (AVROBIO INC) | Long | Equity-common | US | $5M | 403K | 0.11 |
| TENAYA THERAPEUTICS INC | Long | Equity-common | US | $7M | 2M | 0.16 |
| TG THERAPEUTICS INC | Long | Equity-common | US | $20M | 1M | 0.44 |
| TWIST BIOSCIENCE CORP | Long | Equity-common | US | $7M | 167K | 0.16 |
| TYRA BIOSCIENCES INC | Long | Equity-common | US | $1M | 76K | 0.03 |
| TYRA BIOSCIENCES INC PIPE | Long | Equity-common | US | $2M | 115K | 0.04 |
| UCB SA | Long | Equity-common | BE | $77M | 546K | 1.72 |
| ULTRAGENYX PHARMA INC (ULTRAGENYX PHARMACEUTICAL INC) | Long | Equity-common | US | $29M | 726K | 0.65 |
| UNITED THERAPEUTICS CORP DEL | Long | Equity-common | US | $45M | 163K | 1.01 |
| VAXCYTE INC | Long | Equity-common | US | $63M | 900K | 1.42 |
| VENTYX BIOSCIENCES INC | Long | Equity-common | US | $1M | 295K | 0.03 |
| VERA THERAPEUTICS INC | Long | Equity-common | US | $17M | 442K | 0.38 |
| VERONA PHARMA PLC ADR | Long | Equity-common | GB | $9M | 720K | 0.19 |
| VERRICA PHARMACEUTICALS INC | Long | Equity-common | US | $9M | 1M | 0.21 |
| VERTEX PHARMACEUTICALS INC | Long | Equity-common | US | $176M | 386K | 3.93 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $27M | 440K | 0.61 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $12M | 1M | 0.27 |
| VOR BIOPHARMA INC | Long | Equity-common | US | $1M | 992K | 0.03 |
| WAVE LIFE SCIENCES LTD | Long | Equity-common | SG | $4M | 661K | 0.09 |
| XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $21M | 540K | 0.46 |
| ZEALAND PHARMA A/S | Long | Equity-common | DK | $70M | 743K | 1.56 |
| ZENTALIS PHARMACEUTICALS LLC (ZENTALIS PHARMACEUTICALS INC) | Long | Equity-common | US | $7M | 563K | 0.15 |
Address
Fidelity Select Portfolios
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
OSCAR MUNOZ
ROBERT A LAWRENCE
THOMAS A KENNEDY
BETTINA DOULTON
VICKI L FULLER
VIJAY ADVANI
THOMAS P BOSTICK
PATRICIA L KAMPLING
DONALD F DONAHUE
MICHAEL E WILEY
SUSAN TOMASKY
DAVID M THOMAS
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
REFINITIV US HOLDINGS INC
INTERCONTINENTAL EXCHANGE INC
Custodians
CITIBANK N.A. JAKARTA BRANCH
STANDARD CHARTERED BANK (SINGAPORE) LIMITED
STANDARD BANK OF SOUTH AFRICA LIMITED
BANK HAPOALIM BM
RBC INVESTOR SERVICES TRUST
DEUTSCHE BANK AG
HSBC BANK AUSTRALIA LIMITED
HSBC BANK PLC
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) DANMARK BRANCH
HSBC BANK PLC
CITIBANK KOREA INC
BNP PARIBAS S.A. SUCCURSALE ITALIA
CITIBANK ANONIM SIRKETI
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED NEW ZEALAND BRANCH
BNP PARIBAS S.A. ATHENS BRANCH
BNP PARIBAS S.A.
CITIBANK N.A.- MUMBAI BRANCH
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
BNP PARIBAS S.A.
STANDARD CHARTERED BANK (CHINA) LIMITED
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)
MUFG BANK LTD.
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED THAILAND BRANCH
DEUTSCHE BANK AG
BROWN BROTHERS HARRIMAN & CO.
CITIBANK N.A. SAO PAULO
CREDIT SUISSE (SWITZERLAND) LTD.
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) OSLO BRANCH
SOCIETE GENERALE SUCURSAL EN ESPANA
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
B RILEY FINANCIAL INC
BARCLAYS PLC
CITIGROUP INC
MORGAN STANLEY
BANK OF AMERICA CORPORATION
JEFFERIES FINANCIAL GROUP INC
GOLDMAN SACHS GROUP INC (THE)
VIRTU FINANCIAL INC
JPMORGAN CHASE and CO
UBS GROUP AG